Get Live Data

Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Eco Animal Share Price
  4. Eco Animal Share Regulatory News
  5. R&D Day

Pin to quick picksEco Animal Regulatory News (EAH)

Eco Animal Information

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
88.50    0.00 (0.00%)
Bid:
87.00
Ask:
90.00
Spread: 3.00 (3.448%)
Market Cap: £59.37m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

R&D Day

13 Mar 2025 07:00

RNS Number : 4590A
Eco Animal Health Group PLC
13 March 2025
 

13 March 2025

 

 

 

ECO Animal Health Group plc

("ECO" or the "Company")

 

R&D Day

ECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that it is hosting an R&D Day today for institutional and private investors and analysts, with presentations starting at 2:00pm GMT at Andaz London, 40 Liverpool St, London EC2M 7QN.

The event will be led by David Hallas, CEO, and Chris Wilks, CFO, alongside senior leaders from across the Company and an industry expert. Attendees will have the opportunity to gain valuable insights on how the next generation of assets in ECO's R&D pipeline are driving long-term value creation and future proofing the business through innovations in preventative animal health.

For those who would like to join virtually, please register via the dedicated registration page: https://www.equitydevelopment.co.uk/news-and-events/eah-rd-investor-presentation-13march2025.

No new information will be provided on current trading at the R&D Day. For guidance on FY25 trading, the Company asks investors to review the outlook section of the interim results announced on 28 November 2024 as this remains relevant. The Company will provide a trading update for the year ending 31 March 2025 in April 2025.

 

Following the event, slides and a recording will be made available for viewing on the Investors section of the Company's website.

 

 

 

-Ends-

For further information please contact:

ECO Animal Health Group plc

David Hallas (CEO)

Christopher Wilks (CFO)

020 8447 8899

 

Singer Capital Markets (Nominated Adviser & Joint Broker)

Phil Davies

Sam Butcher

020 7496 3000

Investec (Joint Broker)

Gary Clarence

Lydia Zychowska

020 7597 5970

 

 

Equity Development

Hannah Crowe

Matt Evans

020 7065 2692

ICR Healthcare (Financial PR)

Mary-Jane Elliott

Jessica Hodgson

020 3709 5700

ecoanimalhealth@consilium-comms.com

About ECO Animal Health

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. 

Click here for more information: https://ecoanimalhealth.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZGMFLZLGKZM
12345678910
Date   Source Headline
28th Oct 20192:05 pmBUSHolding(s) in Company
28th Oct 20192:03 pmBUSHolding(s) in Company
19th Sep 20193:33 pmBUSResult of AGM
11th Sep 20197:00 amBUSStatement re ECO Animal Health and The Pirbright Institute sign second poultry vaccine development licencing deal.
4th Sep 20198:17 amBUSStatement re ECO Animal Health and The Pirbright Institute sign novel poultry biopharmaceutical development licencing deal
28th Aug 20198:12 amBUSPosting of AGM Notice - Replacement
27th Aug 20191:03 pmBUSCirc re. Posting of AGM Notice
22nd Aug 20197:00 amBUSDirectorate change
19th Aug 20197:00 amBUSDirectorate change
2nd Aug 20192:24 pmBUSHolding(s) in Company
2nd Aug 20191:12 pmBUSCirc re. Posting of Annual Report 2019
1st Aug 20192:17 pmBUSDirector/PDMR Shareholding
1st Aug 20197:00 amBUSTotal Voting Rights
1st Aug 20197:00 amBUSBlock listing Interim Review
8th Jul 20198:23 amBUSHolding(s) in Company
3rd Jul 20197:59 amBUSHolding(s) in Company
19th Jun 20197:00 amBUSFinal Results
5th Jun 201912:43 pmBUSHolding(s) in Company
29th May 20193:13 pmBUSDoc re. Change of Director Responsibilities
2nd Apr 20197:00 amBUSRegulatory Approval
20th Mar 20197:00 amBUSHolding(s) in Company
7th Mar 20197:05 amBUSDirector/PDMR Shareholding
7th Mar 20197:00 amBUSDirectorate change
5th Mar 20197:00 amBUSRegulatory Approval
13th Feb 20197:00 amBUSStatement Re ECO Animal Health and Ghent University Sign Poultry Vaccine Development Licencing Deal
7th Feb 201911:50 amBUSDirector/PDMR Shareholding
5th Feb 20199:58 amBUSHolding(s) in Company
5th Feb 20197:00 amBUSStatement re ECO Animal Health and University of Georgia sign second poultry vaccine development licencing deal
1st Feb 20197:00 amBUSTotal Voting Rights
1st Feb 20197:00 amBUSBlock listing Interim Review
31st Jan 201911:14 amBUSHolding(s) in Company
16th Jan 201910:48 amBUSDirector/PDMR Shareholding
27th Dec 20187:19 amBUSHolding(s) in Company
13th Dec 20183:00 pmBUSHolding(s) in Company
10th Dec 20187:00 amBUSHalf-year Report
5th Dec 201810:31 amBUSHolding(s) in Company
3rd Dec 20187:00 amBUSStatement re ECO Animal Health and Agrinnovation (Yissum) L.P. sign swine antimicrobial novel formulation development and licencing deal
27th Nov 20189:32 amBUSNotice of Results
19th Nov 20187:00 amBUSStatement re Joint poultry vaccine development licencing deal
7th Nov 20187:00 amBUSRegulatory Approval
1st Nov 20183:40 pmBUSHolding(s) in Company
1st Nov 20183:01 pmBUSHolding(s) in Company
26th Oct 20187:48 amBUSDirector/PDMR Shareholding
16th Oct 201811:26 amBUSHolding(s) in Company
20th Jul 20182:09 pmBUSDirector/PDMR Shareholding
18th Jul 201810:06 amBUSHolding(s) in Company
18th Jul 201810:01 amBUSHolding(s) in Company
10th Jul 20188:58 amBUSHolding(s) in Company
3rd Jul 20189:05 amBUSHolding(s) in Company
3rd Jul 20189:03 amBUSHolding(s) in Company
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
SML
Strategic Minerals
LSE
0.75%
RIII
Rights &iss.
LSE
0.46%
HHI
Henderson High Income Trust
LSE
-0.50%
BEE
BEE.L
LSE
0.00%
BPI
BPI.L
LSE
0.00%
Trending
MAC
Marechale Cap.
LSE
0.00%
GGP
Greatland Resources
LSE
1.74%
GST
GSTechnologies
LSE
0.00%
KEFI
Kefi Gold & Copper
LSE
2.75%
ITM
Itm Power
LSE
-0.54%